The future looks bright for medicalization and the therapeutic nanny state. As an article in WebMD about a World Health Organization report, just out, puts it, Study: Mental Health Is Top Concern for Youth:
In the report, researchers find three main causes of disability in those ages 10 through 24, says researcher Colin Mathers, PhD, a scientist at WHO in Geneva. The top three are neuropsychiatric disorders, unintentional injuries, and infectious and parasitic diseases.
“Mental illness” labeling is not only among the top 3 causes of disability, but it tops the other two by a wide margin.
Worldwide, the three main causes of years lost due to disability for the entire age range, 10 to 24, and their contribution, were:
• Neuropsychiatric disorders: 45%
• Unintentional injuries: 12%
• Infectious and parasitic diseases: 10%
Don’t be confused by the neuro attached to psychiatric. This is just biological psychiatry at work trying to confuse people, and to make psychiatric look more biological, medical, scientific and potentially devestating than it need be. It’s still just plain old psych labels to me.
Childhood “mental illness” labels have come of age apparently, and children with “mental illness” labels tend to grow into adults with “mental illness” labels.
“Increasingly, we are starting to realize the onset of about half of all lifetime cases of mental illness begin by age 14,” he [Kenneth Duckworth, MD, medical director for NAMI] says.
Once upon a time labeling children was very rare. No more apparently.
Although Dr. Duckworth attributes this figure to the human condition, the psychiatric labeling of children and adolescents has taken off in the last few years like never before in history. If Dr. Duckworth were to review statistics over the course of time, I think he would find this escalation in kiddy psychiatric disability much more of a human generated phenomenon than he seems ready and willing to concede at the present moment.
A subject the article doesn’t speculate upon is how much of this disability might be due to pharmaceutical corporations expanding the market for brain-disabling drugs into countries where the use of such products had not been previously established.